Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT04752215 |
Title | A Study Evaluating Different Doses of BI 765049 When Given Alone and When Given With Ezabenlimab to Patients With Advanced Solid Tumors Having the B7-H6 Marker |
Recruitment | Recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Boehringer Ingelheim |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Valkyrie Clinical Trials | Recruiting | Los Angeles | California | 90067 | United States | Details |
HealthONE | Recruiting | Denver | Colorado | 80218 | United States | Details |
Florida Cancer Specialists | Recruiting | Sarasota | Florida | 34232 | United States | Details |
Stephenson Cancer Center | Recruiting | Oklahoma City | Oklahoma | 73104 | United States | Details |
Tennessee Oncology, PLLC | Recruiting | Nashville | Tennessee | 37203 | United States | Details |
Mary Crowley Cancer Research Center | Recruiting | Dallas | Texas | 75230 | United States | Details |